New hope for Tough-to-Treat lung cancer: testing a Two-Drug combo
NCT ID NCT05941897
Summary
This study is testing whether a new combination of two drugs, ceralasertib (a pill) and durvalumab (an IV infusion), can help control advanced non-small cell lung cancer. It is for adults whose cancer has continued to grow despite receiving standard immunotherapy and chemotherapy. The main goal is to see if the treatment shrinks tumors and is safe for patients in Russia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC NSCLC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Moscow, 111123, Russia
-
Research Site
Moscow, 115478, Russia
-
Research Site
Moscow, 115533, Russia
-
Research Site
Moscow, 125284, Russia
-
Research Site
Moscow, 143423, Russia
-
Research Site
Nizhny Novgorod, 603126, Russia
-
Research Site
Saint Petersburg, 197758, Russia
-
Research Site
Saint Petersburg, 198255, Russia
Conditions
Explore the condition pages connected to this study.